Page last updated: 2024-10-19

melatonin and Cardiovascular Diseases

melatonin has been researched along with Cardiovascular Diseases in 56 studies

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"In the past year, studies have focused on the mechanism of protection of melatonin on cardiovascular diseases, including myocardial ischemia-reperfusion injury, myocardial hypoxia-reoxygenation injury, pulmonary hypertension, hypertension, atherosclerosis, valvular heart diseases, and other cardiovascular diseases."8.93Effects of melatonin on cardiovascular diseases: progress in the past year. ( Gusdon, AM; Qu, S; Sun, H, 2016)
"The aim of this study was to evaluate the effects of melatonin on the oxidative stress in heart tissues after induction of experimental periodontitis in rats."7.85Antioxidant effects of melatonin in heart tissue after induction of experimental periodontitis in rats. ( Fentoğlu, Ö; Kırzıoğlu, FY; Koçak, A; Özdem, M; Uz, E; Vural, H; Yiğit, A; Yılmaz, HR, 2017)
"Circadian disruptions can contribute to accelerated aging, and the circadian system regulates cognitive and physical functions; therefore, circadian markers (eg, melatonin) may be associated with key aspects of healthy aging and longevity."7.83Association of urinary melatonin levels and aging-related outcomes in older men. ( Ancoli-Israel, S; Barrett-Connor, E; Cawthon, PM; Devore, EE; Ensrud, K; Harrison, SL; Holton, KF; Orwoll, E; Redline, S; Schernhammer, ES; Stone, KL; Yaffe, K, 2016)
"Vascular inflammation is one of the main activating stimuli of cardiovascular disease and its uncontrolled development may worsen the progression and prognosis of these pathologies."6.82Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved. ( Chuffa, LGA; Manucha, W; Martín Giménez, VM; Reiter, RJ; Simão, VA, 2022)
"Melatonin is an anti-inflammatory and antioxidant agent with a wide range of therapeutic properties."6.82Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties. ( Dehdashtian, E; Hosseinzadeh, A; Mehrzadi, S; Pourhanifeh, MH; Sezavar, SH, 2022)
" Based on these data, we conducted an open-label randomized study, first, to evaluate the endothelial damage and vascular stiffness in hypertense patients; second, to test the effect of supplementation with a physiological antioxidant (melatonin 1 mg/day for 1 year) in patients with essential hypertension vs."5.51Essential Hypertension and Oxidative Stress: Novel Future Perspectives. ( Bonomini, F; Favero, G; Franco, C; Rezzani, R; Sciatti, E; Vizzardi, E, 2022)
" Melatonin, a biologically active substance, acts as a pleiotropic hormone essential for pregnancy and fetal development."5.01Perinatal Use of Melatonin for Offspring Health: Focus on Cardiovascular and Neurological Diseases. ( Hsu, CN; Huang, LT; Tain, YL, 2019)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
"The aim of this study was to evaluate the effects of melatonin on the oxidative stress in heart tissues after induction of experimental periodontitis in rats."3.85Antioxidant effects of melatonin in heart tissue after induction of experimental periodontitis in rats. ( Fentoğlu, Ö; Kırzıoğlu, FY; Koçak, A; Özdem, M; Uz, E; Vural, H; Yiğit, A; Yılmaz, HR, 2017)
"Circadian disruptions can contribute to accelerated aging, and the circadian system regulates cognitive and physical functions; therefore, circadian markers (eg, melatonin) may be associated with key aspects of healthy aging and longevity."3.83Association of urinary melatonin levels and aging-related outcomes in older men. ( Ancoli-Israel, S; Barrett-Connor, E; Cawthon, PM; Devore, EE; Ensrud, K; Harrison, SL; Holton, KF; Orwoll, E; Redline, S; Schernhammer, ES; Stone, KL; Yaffe, K, 2016)
"To study disturbances of sleep and circadian rhythms in patients with cardiovascular diseases taking into account the level of melatonin secretion and to optimize a complex approach to their treatment."3.81[Sleep disorders and circadian rhythms in diseases of the cardiovascular system]. ( Eneeva, MA; Kamchatnov, PR; Kostenko, EV; Petrova, LV, 2015)
"The melatonin levels decreased with aging despite not reaching statistical significance, and the decrease was more evident in males than in females (40."3.80Melatonin and the Charlson Comorbidity Index (CCI): the Treviso Longeva (Trelong) study. ( Albani, D; Boldrini, P; Caberlotto, L; Di Giorgi, E; Durante, E; Flores-Obando, R; Forloni, G; Frigato, A; Gallucci, M; Mazzuco, S; Ongaro, F; Siculi, M; Taioli, E; Zanardo, A, 2014)
"Vascular inflammation is one of the main activating stimuli of cardiovascular disease and its uncontrolled development may worsen the progression and prognosis of these pathologies."2.82Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved. ( Chuffa, LGA; Manucha, W; Martín Giménez, VM; Reiter, RJ; Simão, VA, 2022)
"Cardiovascular diseases are one of the most common causes of mortality and morbidity among elderly subjects worldwide."2.55Melatonin: Protection against age-related cardiac pathology. ( Buffoli, B; Favero, G; Franceschetti, L; Moghadasian, MH; Reiter, RJ; Rezzani, R; Rodella, LF, 2017)
"Melatonin was reported to prevent mitochondrial dysfunction from oxidative damage by preserving cardiolipin integrity, and this may explain, at least in part, the beneficial effect of this compound in mitochondrial physiopathology."2.52Protective role of melatonin in mitochondrial dysfunction and related disorders. ( Paradies, G; Paradies, V; Petrosillo, G; Ruggiero, FM, 2015)
" The recognition of the periodicity of biological processes makes the optimal dosing of certain drugs feasible."2.48[Physiological and pathophysiological role of the circadian clock system]. ( Halmos, T; Suba, I, 2012)
"Melatonin has been also used as a complementary treatment in anaesthesia, hemodialysis, in vitro fertilization and neonatal care."2.46Clinical uses of melatonin: evaluation of human trials. ( Mediavilla, MD; Reiter, RJ; Sánchez-Barceló, EJ; Tan, DX, 2010)
"Melatonin has antioxidant, anti-inflammatory, chronobiotic and, possibly, epigenetic regulatory functions."2.46Melatonin and circadian biology in human cardiovascular disease. ( Abreu-Gonzalez, P; Dominguez-Rodriguez, A; Kaski, JC; Reiter, RJ; Sanchez-Sanchez, JJ, 2010)
"The purpose of the study was to assess whether it is possible to reduce the oxidative damage using antioxidant agents combined with hormone replacement therapy after menopause."1.39Effects of melatonin and dexpanthenol on antioxidant parameters when combined with estrogen treatment in ovariectomized rats. ( Ay, A; Ay, AA; Dost, T; Kafkas, S; Turgut, H; Turgut, O, 2013)
"Nicotine treatment induced marked endothelial damage and an obvious vasoconstriction in the aorta as evaluated by an increased endothelin-1 (ET-1) expression."1.36Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. ( Favero, G; Foglio, E; Reiter, RJ; Rezzani, R; Rodella, LF; Rossini, C, 2010)
"Each subject's risk of developing breast cancer, cardiovascular diseases resulting from an elevated blood pressure, and emotional conditions was numerically evaluated according to epidemiologic questionnaires."1.27Circadian characteristics of urinary melatonin from clinically healthy young women at different civilization disease risks. ( Cornelissen, G; Halberg, E; Halberg, F; Haus, E; Kawasaki, T; Matsuoka, M; Omae, T; Ueno, M; Uezono, K; Wetterberg, L, 1986)

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-19903 (5.36)18.7374
1990's1 (1.79)18.2507
2000's7 (12.50)29.6817
2010's32 (57.14)24.3611
2020's13 (23.21)2.80

Authors

AuthorsStudies
Martín Giménez, VM1
Chuffa, LGA1
Simão, VA1
Reiter, RJ13
Manucha, W1
Golding, H1
Ritonja, JA1
Day, AG1
Aronson, KJ1
Tranmer, J1
Franco, C3
Sciatti, E3
Favero, G5
Bonomini, F3
Vizzardi, E3
Rezzani, R6
Taha, AM1
Mahmoud, AM1
Ghonaim, MM1
Kamran, A1
AlSamhori, JF1
AlBarakat, MM1
Shrestha, AB1
Jaiswal, V1
Hannemann, J1
Skene, DJ1
Middleton, B1
Schwedhelm, E1
Laing, A1
Böger, R1
Covassin, N1
Somers, VK1
Ostadmohammadi, V1
Soleimani, A1
Bahmani, F1
Aghadavod, E1
Ramezani, R1
Mansournia, MA1
Banikazemi, Z1
Soleimani, M1
Zaroudi, M1
Asemi, Z1
Hsu, CN1
Huang, LT1
Tain, YL1
Imenshahidi, M1
Karimi, G1
Hosseinzadeh, H1
Domínguez-Rodríguez, A5
Abreu-González, P4
Marik, PE1
García-Blas, S1
Díez-Villanueva, P1
Tarazona-Santabalbina, F1
Bonanad, C1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J6
Xue, L1
Liu, L2
Yan, X2
Huang, S1
Li, Y6
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X2
Chen, Y4
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S1
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X4
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y4
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X1
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Liu, Y2
Zhang, Q1
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X1
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z2
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H3
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y1
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C1
Zhang, X1
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Pourhanifeh, MH1
Dehdashtian, E1
Hosseinzadeh, A1
Sezavar, SH1
Mehrzadi, S1
Bazyar, H1
Zare Javid, A1
Bavi Behbahani, H1
Moradi, F1
Moradi Poode, B1
Amiri, P1
Özdem, M1
Kırzıoğlu, FY1
Yılmaz, HR1
Vural, H1
Fentoğlu, Ö1
Uz, E1
Koçak, A1
Yiğit, A1
Zisapel, N1
Obayashi, K1
Saeki, K1
Savran, M1
Asci, H1
Ozmen, O1
Erzurumlu, Y1
Savas, HB1
Sonmez, Y1
Sahin, Y1
Turgut, O1
Ay, AA1
Turgut, H1
Ay, A1
Kafkas, S1
Dost, T1
Nakao, T1
Morita, H1
Maemura, K1
Amiya, E1
Inajima, T1
Saito, Y1
Watanabe, M1
Manabe, I1
Kurabayashi, M1
Nagai, R1
Komuro, I1
Arushanian, ÉB3
Gallucci, M1
Flores-Obando, R1
Mazzuco, S1
Ongaro, F1
Di Giorgi, E1
Boldrini, P1
Durante, E1
Frigato, A1
Albani, D1
Forloni, G1
Zanardo, A1
Siculi, M1
Caberlotto, L1
Taioli, E1
Boivin, DB1
Boudreau, P1
Paredes, SD2
Forman, KA1
García, C1
Vara, E1
Escames, G1
Tresguerres, JA1
Paradies, G1
Paradies, V1
Ruggiero, FM1
Petrosillo, G1
Takaesu, Y1
Futenma, K1
Kobayashi, M1
Komada, Y1
Tanaka, N1
Yamashina, A1
Inoue, Y1
Kostenko, EV1
Petrova, LV1
Eneeva, MA1
Kamchatnov, PR1
Mitsiev, AK1
Sun, H1
Gusdon, AM1
Qu, S1
Devore, EE1
Harrison, SL1
Stone, KL1
Holton, KF1
Barrett-Connor, E1
Ancoli-Israel, S1
Yaffe, K1
Ensrud, K1
Cawthon, PM1
Redline, S1
Orwoll, E1
Schernhammer, ES1
Franceschetti, L1
Buffoli, B1
Moghadasian, MH1
Rodella, LF3
Sánchez-Barceló, EJ1
Mediavilla, MD1
Tan, DX3
Fuentes-Broto, L1
Sanchez-Sanchez, JJ1
Kaski, JC1
Rossini, C1
Foglio, E1
Masue, T1
Wada, K1
Hayashi, M1
Takeda, N1
Yasuda, K1
Deguchi, T1
Nagata, C1
Korkushko, OV1
Khavinson, VKh1
Shatilo, VB1
Antonyk-Sheglova, IA1
Vogel, M1
Braungardt, T1
Meyer, W1
Schneider, W1
Paulis, L1
Simko, F1
Laudon, M1
Halmos, T1
Suba, I1
Holmes, AL1
Burgess, HJ1
McCulloch, K1
Lamond, N1
Fletcher, A1
Dorrian, J1
Roach, G1
Dawson, D1
Grote, L1
Altun, A1
Ugur-Altun, B1
Rapoport, SI1
Smirnova, AV1
Naumcheva, NN1
Gaĭdash, SP1
Tengattini, S1
Terron, MP1
Horrobin, DF1
Cagnacci, A2
Arangino, S2
Angiolucci, M2
Maschio, E1
Longu, G1
Melis, GB2
Okatani, Y1
Wakatsuki, A1
Facchinetti, F1
Malmusi, S1
Volpe, A1
Rachinskiĭ, ID1
Wetterberg, L1
Halberg, F1
Halberg, E1
Haus, E1
Kawasaki, T1
Ueno, M1
Uezono, K1
Cornelissen, G1
Matsuoka, M1
Omae, T1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Triple Blinded Randomized Controlled Trial of Oral Melatonin in Elevated Blood Pressure Individual (MRCTEBP)[NCT03764020]Phase 3320 participants (Anticipated)Interventional2019-06-01Not yet recruiting
Melatonin and Essential Arterial Hypertension[NCT05257291]Phase 223 participants (Actual)Interventional2018-02-02Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

25 reviews available for melatonin and Cardiovascular Diseases

ArticleYear
Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved.
    Life sciences, 2022, Jan-01, Volume: 288

    Topics: Animals; Antioxidants; Arachidonic Acids; Calcium Channel Blockers; Cardiovascular Diseases; Endocan

2022
Melatonin as a potential treatment for septic cardiomyopathy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 166

    Topics: Antioxidants; Cardiomyopathies; Cardiovascular Diseases; Humans; Melatonin; Sepsis

2023
Perinatal Use of Melatonin for Offspring Health: Focus on Cardiovascular and Neurological Diseases.
    International journal of molecular sciences, 2019, Nov-13, Volume: 20, Issue:22

    Topics: Animals; Antioxidants; Cardiovascular Diseases; Female; Fetal Development; Fetal Diseases; Humans; I

2019
Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review.
    Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:4

    Topics: Animals; Antioxidants; Cardiovascular Diseases; Free Radical Scavengers; Heart Disease Risk Factors;

2020
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Humans

2022
New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation.
    British journal of pharmacology, 2018, Volume: 175, Issue:16

    Topics: Animals; Cardiovascular Diseases; Circadian Rhythm; Humans; Melatonin; Nervous System Diseases; Slee

2018
[Thermal and Lighting Housing Environments and Circadian Blood Pressure Variability: Findings from the HEIJO-KYO Cohort].
    Nihon eiseigaku zasshi. Japanese journal of hygiene, 2018, Volume: 73, Issue:2

    Topics: Aged; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Cohort Studies; Co

2018
[Effect of melatonin on the thrombocyte hemostasis and its circadian organization].
    Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:5

    Topics: Animals; Blood Platelets; Cardiovascular Diseases; Circadian Rhythm; Hemostasis; Humans; Melatonin

2013
Impacts of shift work on sleep and circadian rhythms.
    Pathologie-biologie, 2014, Volume: 62, Issue:5

    Topics: Accidents; Arousal; Automobile Driving; Cardiovascular Diseases; Circadian Rhythm; Circadian Rhythm

2014
Protective actions of melatonin and growth hormone on the aged cardiovascular system.
    Hormone molecular biology and clinical investigation, 2014, Volume: 18, Issue:2

    Topics: Aging; Animals; Antioxidants; Apoptosis; Cardiovascular Diseases; Cardiovascular System; Growth Horm

2014
Protective role of melatonin in mitochondrial dysfunction and related disorders.
    Archives of toxicology, 2015, Volume: 89, Issue:6

    Topics: Animals; Antioxidants; Cardiolipins; Cardiovascular Diseases; Diabetes Mellitus; Humans; Melatonin;

2015
[Role of renin-angiotensin system in cardiovascular effects of melatonin].
    Eksperimental'naia i klinicheskaia farmakologiia, 2015, Volume: 78, Issue:3

    Topics: Animals; Cardiovascular Diseases; Humans; Melatonin; Renin-Angiotensin System

2015
[Possibility of melatonine prevention of cardiovascular diseases caused by heavy metals in experiment].
    Meditsina truda i promyshlennaia ekologiia, 2015, Issue:5

    Topics: Antioxidants; Cardiovascular Diseases; Humans; Melatonin; Metals, Heavy; Occupational Diseases; Occu

2015
Effects of melatonin on cardiovascular diseases: progress in the past year.
    Current opinion in lipidology, 2016, Volume: 27, Issue:4

    Topics: Animals; Cardiovascular Diseases; Cell Hypoxia; Humans; Lipid Metabolism; Melatonin

2016
Melatonin: Protection against age-related cardiac pathology.
    Ageing research reviews, 2017, Volume: 35

    Topics: Aging; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Diet, Healthy; Dietary Supplements

2017
Clinical uses of melatonin: evaluation of human trials.
    Current medicinal chemistry, 2010, Volume: 17, Issue:19

    Topics: Cardiovascular Diseases; Clinical Trials as Topic; Communicable Diseases; Endocrine System Diseases;

2010
Beneficial effects of melatonin in cardiovascular disease.
    Annals of medicine, 2010, May-06, Volume: 42, Issue:4

    Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Drug-Related Side Effects and Ad

2010
Melatonin and circadian biology in human cardiovascular disease.
    Journal of pineal research, 2010, Volume: 49, Issue:1

    Topics: Cardiovascular Diseases; Circadian Rhythm; Humans; Melatonin

2010
[Pineal hormone melatonin in complex pharmacotherapy of brain and somatic disorders].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:9

    Topics: Animals; Brain Diseases; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Gastroi

2011
The effects of shift work on physical and mental health.
    Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:10

    Topics: Adaptation, Physiological; Adaptation, Psychological; Cardiovascular Diseases; Circadian Rhythm; Cog

2012
Cardiovascular effects of melatonin receptor agonists.
    Expert opinion on investigational drugs, 2012, Volume: 21, Issue:11

    Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Circadian Rhythm; Drug Design; Humans; Mela

2012
[Physiological and pathophysiological role of the circadian clock system].
    Orvosi hetilap, 2012, Sep-02, Volume: 153, Issue:35

    Topics: Aging; ARNTL Transcription Factors; Blood Coagulation Disorders; Cardiovascular Diseases; Circadian

2012
Melatonin: therapeutic and clinical utilization.
    International journal of clinical practice, 2007, Volume: 61, Issue:5

    Topics: Cardiovascular Diseases; Circadian Rhythm; Humans; Immune System; Immune System Diseases; Jet Lag Sy

2007
Cardiovascular diseases: protective effects of melatonin.
    Journal of pineal research, 2008, Volume: 44, Issue:1

    Topics: Animals; Cardiovascular Diseases; Free Radical Scavengers; Humans; Melatonin; Oxidative Stress

2008

Trials

7 trials available for melatonin and Cardiovascular Diseases

ArticleYear
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
Essential Hypertension and Oxidative Stress: Novel Future Perspectives.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Antioxidants; Cardiovascular Diseases; Essential Hypertension; Humans; Hypertension; Melatonin; Oxid

2022
The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2020, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antioxidants; Biomarkers; Blood Glucose; Cardiovascular

2020
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial.
    Trials, 2021, Mar-25, Volume: 22, Issue:1

    Topics: Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dietar

2021
Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up.
    Bulletin of experimental biology and medicine, 2011, Volume: 151, Issue:3

    Topics: Aged; Aging; Blood Glucose; Carbohydrate Metabolism; Cardiovascular Diseases; Cardiovascular System;

2011
Potentially beneficial cardiovascular effects of melatonin administration in women.
    Journal of pineal research, 1997, Volume: 22, Issue:1

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Double-Blind Method; Female; Human

1997
Potentially beneficial cardiovascular effects of melatonin administration in women.
    Journal of pineal research, 1997, Volume: 22, Issue:1

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Double-Blind Method; Female; Human

1997
Potentially beneficial cardiovascular effects of melatonin administration in women.
    Journal of pineal research, 1997, Volume: 22, Issue:1

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Double-Blind Method; Female; Human

1997
Potentially beneficial cardiovascular effects of melatonin administration in women.
    Journal of pineal research, 1997, Volume: 22, Issue:1

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Double-Blind Method; Female; Human

1997
Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy.
    Clinical endocrinology, 2001, Volume: 54, Issue:2

    Topics: Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Carotid Artery, Internal; Double-Blin

2001

Other Studies

25 other studies available for melatonin and Cardiovascular Diseases

ArticleYear
Modeling the relationship between shift work and cardiometabolic risk through circadian disruption, sleep and stress pathways.
    Chronobiology international, 2022, Volume: 39, Issue:5

    Topics: Cardiovascular Diseases; Circadian Rhythm; Cross-Sectional Studies; Female; Humans; Hydrocortisone;

2022
Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls.
    Biomolecules, 2023, 08-22, Volume: 13, Issue:9

    Topics: Amino Acids; Arginine; Cardiovascular Diseases; Heart Disease Risk Factors; Homoarginine; Humans; Hy

2023
Sleep, melatonin, and cardiovascular disease.
    The Lancet. Neurology, 2023, Volume: 22, Issue:11

    Topics: Cardiovascular Diseases; Circadian Rhythm; Humans; Melatonin; Sleep; Sleep Wake Disorders

2023
Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have!
    Revista espanola de cardiologia (English ed.), 2020, Volume: 73, Issue:12

    Topics: Aged; Cardiology; Cardiovascular Diseases; Coronavirus; Geriatrics; Humans; Joints; Melatonin

2020
Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have! Response.
    Revista espanola de cardiologia (English ed.), 2020, Volume: 73, Issue:12

    Topics: Aged; Cardiovascular Diseases; Coronavirus; Emergency Service, Hospital; Humans; Melatonin

2020
Antioxidant effects of melatonin in heart tissue after induction of experimental periodontitis in rats.
    Journal of oral science, 2017, Volume: 59, Issue:1

    Topics: Animals; Antioxidants; Cardiovascular Diseases; Heart; Male; Melatonin; Oxidative Stress; Periodonti

2017
Melatonin protects the heart and endothelium against high fructose corn syrup consumption-induced cardiovascular toxicity via SIRT-1 signaling.
    Human & experimental toxicology, 2019, Volume: 38, Issue:10

    Topics: Animals; Aorta; Biomarkers; Cardiotoxicity; Cardiovascular Diseases; Endothelium, Vascular; Heart; H

2019
Effects of melatonin and dexpanthenol on antioxidant parameters when combined with estrogen treatment in ovariectomized rats.
    Age (Dordrecht, Netherlands), 2013, Volume: 35, Issue:6

    Topics: Animals; Antioxidants; Cardiovascular Diseases; Disease Models, Animal; Drug Therapy, Combination; E

2013
Melatonin ameliorates angiotensin II-induced vascular endothelial damage via its antioxidative properties.
    Journal of pineal research, 2013, Volume: 55, Issue:3

    Topics: Angiotensin II; Antioxidants; Cardiovascular Diseases; Cells, Cultured; Endothelial Cells; Endotheli

2013
Melatonin and the Charlson Comorbidity Index (CCI): the Treviso Longeva (Trelong) study.
    The International journal of biological markers, 2014, Sep-30, Volume: 29, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Cohort Studies; Comorbidity; E

2014
A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit.
    Chronobiology international, 2015, Volume: 32, Issue:6

    Topics: Actigraphy; Cardiovascular Diseases; Case-Control Studies; Coronary Care Units; Critical Care; Femal

2015
[Sleep disorders and circadian rhythms in diseases of the cardiovascular system].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:3

    Topics: Aged; Cardiovascular Diseases; Circadian Rhythm; Cognition Disorders; Female; Humans; Male; Melatoni

2015
Association of urinary melatonin levels and aging-related outcomes in older men.
    Sleep medicine, 2016, Volume: 23

    Topics: Aged; Aging; Cardiovascular Diseases; Cognition; Cohort Studies; Humans; Male; Melatonin; Mortality;

2016
Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time.
    Cardiovascular drugs and therapy, 2017, Volume: 31, Issue:2

    Topics: Cardiovascular Diseases; Electrocardiography; Humans; Melatonin; Myocardial Infarction; Myocardial R

2017
Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy.
    Life sciences, 2010, Oct-23, Volume: 87, Issue:17-18

    Topics: Animals; Aorta; Biomarkers; Cardiovascular Diseases; Endothelin-1; Endothelium, Vascular; HSP70 Heat

2010
Associations of urinary 6-sulfatoxymelatonin with biomarkers related to cardiovascular disease in Japanese women.
    Metabolism: clinical and experimental, 2012, Volume: 61, Issue:1

    Topics: Asian People; Biomarkers; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Dise

2012
Melatonin and cardiovascular disease: myth or reality?
    Revista espanola de cardiologia (English ed.), 2012, Volume: 65, Issue:3

    Topics: Antioxidants; Cardiovascular Diseases; Circadian Rhythm; Humans; Melatonin; Myocardial Infarction

2012
Melatonin in cardiovascular disease.
    Expert opinion on investigational drugs, 2012, Volume: 21, Issue:11

    Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Free Radical Scavengers; Humans; Melatonin; Mo

2012
Daytime cardiac autonomic activity during one week of continuous night shift.
    Journal of human ergology, 2001, Volume: 30, Issue:1-2

    Topics: Adolescent; Adult; Arousal; Autonomic Nervous System; Cardiography, Impedance; Cardiovascular Diseas

2001
[Influence of circadian rhythms on cardiovascular function].
    Der Internist, 2004, Volume: 45, Issue:9

    Topics: Biological Clocks; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Circadian Rhythm;

2004
[The first experience in application of melatonin (melaxen) for prophylaxis of the effects of magnetic storms on patients with cardiovascular pathology].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:8

    Topics: Antioxidants; Cardiovascular Diseases; Electromagnetic Fields; Female; Humans; Hypertension; Male; M

2007
A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2.
    Medical hypotheses, 1980, Volume: 6, Issue:8

    Topics: Cardiovascular Diseases; Cholesterol; Collagen; Fatty Acids, Essential; Feedback; Humans; Insulin; L

1980
Melatonin counteracts potentiation by homocysteine of KCL-induced vasoconstriction in human umbilical artery: relation to calcium influx.
    Biochemical and biophysical research communications, 2001, Jan-26, Volume: 280, Issue:3

    Topics: Antioxidants; Calcium Signaling; Cardiovascular Diseases; Drug Interactions; Female; Free Radical Sc

2001
[Disordered melatonin metabolism in chronic circulatory insufficiency].
    Kardiologiia, 1978, Volume: 18, Issue:12

    Topics: Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Humans; Hype

1978
Circadian characteristics of urinary melatonin from clinically healthy young women at different civilization disease risks.
    Acta medica Scandinavica, 1986, Volume: 220, Issue:1

    Topics: Adolescent; Adult; Breast Neoplasms; Cardiovascular Diseases; Circadian Rhythm; Depression; Female;

1986